4-73064834-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001297732.2(COX18):āc.667G>Cā(p.Asp223His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001297732.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX18 | NM_001297732.2 | c.667G>C | p.Asp223His | missense_variant | 4/6 | ENST00000507544.3 | NP_001284661.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX18 | ENST00000507544.3 | c.667G>C | p.Asp223His | missense_variant | 4/6 | 1 | NM_001297732.2 | ENSP00000425261.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461602Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727098
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Mitochondrial complex IV deficiency, nuclear type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Department of Pathophysiology and Transplantation, University of Milan | Jun 18, 2023 | Gene COX18 has no reported pathogenic variants. Previous basic investigations has explored the role of COX18 genetic inactivation on the stability and assembly of human Cytochrome c Oxidase (COX) (see the reference) We have identified a rare variant in in COX18 associated with isolated COX deficiency in a neonatal patient presenting cardiomyopathy and severe muscle weakness with documented COX deficiency. A huge set of experiment in vitro (biochemical and functional studies in patient's cells) and ex-vivo (histochemical and biochemical assessment of patient's muscle biopsy) were performed to sustain the pathogenicity of the variant. ACMG classification before our investigations: VUS (PM2+BP4). ACMG classification after our investigations: Pathogenic PS (PP3) + PS3 (functional studies). Indeed: PP3 criteria achieved considering MetaRNN = 0.973 is greater than 0.939 ā strong pathogenic. PS3 criterion achieved (several lines of evidence supporting the role of the identified variant on COX stability, assembly, function). PM2 criterion achieved Variant not found in gnomAD genomes, good gnomAD genomes coverage = 32.6. Variant not found in gnomAD exomes, good gnomAD exomes coverage = 74.7. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.